WILMINGTON, De / ACCESSWIRE / January 21, 2020 / Rigrodsky & Long, P.A.:
- Do you own shares of Neon Therapeutics, Inc. (NASDAQ GS:NTGN)?
- Did you purchase any of your shares prior to January 16, 2020?
- Do you think the proposed merger is fair?
- Do you want to discuss your rights?
Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors Neon Therapeutics, Inc. ("Neon" or the "Company") (NASDAQ GS: NTGN) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by BioNTech SE ("BioNTech") (NASDAQ GS: BNTX) in a transaction valued at approximately $67 million. Under the terms of the agreement, shareholders of Neon will receive 0.063 American Depository Shares, which are equivalent to one ordinary share of BioNTech, for each share of Neon they own.
If you own common stock of Neon and purchased any shares before January 16, 2020, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra toll-free at (888) 969-4242, by e-mail at info@rl-legal.com, or at https://www.rigrodskylong.com/offices-contact.
Rigrodsky & Long, P.A., with offices in Delaware, New York, and California, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in numerous cases nationwide, including federal securities fraud actions, shareholder class actions, and shareholder derivative actions.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT:
Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
http://www.rigrodskylong.com
SOURCE: Rigrodsky & Long, P.A.
View source version on accesswire.com:
https://www.accesswire.com/573320/NEON-THERAPEUTICS-INC-SHAREHOLDER-ALERT-Rigrodsky-Long-PA-Announces-Investigation-Of-Merger
